Electrophysiological Effects of Late PCI After MI
Cardiovascular Diseases, Heart Diseases, Myocardial Infarction
About this trial
This is an interventional treatment trial for Cardiovascular Diseases focused on measuring Stents, myocardial infarction
Eligibility Criteria
Inclusion Criteria: Has experienced a heart attack 3 to 28 days prior to study entry Persistently occluded IRA defined as either: 1) Thrombolysis in Myocardial Infarction (TIMI) 0, with no flow beyond the site of occlusion; or 2) TIMI 1, with penetration of dye beyond the site of occlusion without dye reaching the distal vessel LVEF less than 50% or proximal occlusion in a large vessel Normal sinus rhythm QRS duration less than 120 ms Able to return for follow-up assessment of arrhythmia markers one month and one year after study entry Exclusion Criteria: Has a clinical indication for revascularization (post-heart attack angina at rest; significant inducible ischemia; or significant left main or triple vessel disease requiring PTCA or CABG) Current serious illness or condition that limits 3-year survival Severe valvular disease Chronic total occlusion New York Heart Association Class III-IV congestive heart failure Prior left ventricular aneurysm in the recent heart attack location Is a poor candidate for PTCA/stent on the basis of angiographic or clinical criteria Cannot medically survive anticoagulation during PTCA/stent or antiplatelet therapy after stent Pregnant
Sites / Locations
- Stony Brook University Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
PCI+MED
MED
Percutaneous Coronary Intervention (PCI) with angioplasty and stenting of the infarct-related artery and optimal medical therapy
Optimal medical therapy alone